Quinoline derivatives for use as mycobacterial inhibitors

Details for Australian Patent Application No. 2005210036 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Lancois, David Francis Alain; Guillemont, Jerome Emile Georges; Pasquier, Elisabeth Therese Jeanne

Agent Shelston IP

Pub. Number AU-B-2005210036

PCT Pub. Number WO2005/075428

Priority 04075286.7 29.01.04 EP

Filing date 28 January 2005

Wipo publication date 18 August 2005

Acceptance publication date 23 December 2010

International Classifications

C07D 215/18 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/075428 Priority application(s): WO2005/075428

23 December 2010 Application Accepted

  Published as AU-B-2005210036

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005210039-Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands

2005210032-Macrolides with antiinflammatory activity